Stay updated on AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial
Sign up to get notified when there's something new on the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page.

Latest updates to the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now displays Revision v3.6.5, replacing the previous v3.6.4. This indicates an incremental update to the build, with no explicit content changes described by the data.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe site revision has been updated from v3.6.3 to v3.6.4, indicating a new deployment. The update does not modify the study content or user-facing functions on this page.SummaryDifference0.0%

- Check44 days agoChange DetectedVersion revision on the page was updated from v3.6.2 to v3.6.3, representing a minor update to the site's page template or backend. No study content or data changes are implied by this update.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision: v3.6.2 appears on the page, replacing the previous v3.6.0. This indicates a minor platform update rather than changes to the study data.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded posted results for the AFPc332T study (NCT03132792), including safety endpoints (DLTs, TEAEs, SAEs), efficacy endpoints (ORR, DoR, PFS, OS), and enrollment details (39 participants). Also added access to official documents (Study Protocol and SAP) and updated results timing information (results posted/submitted dates).SummaryDifference3%

- Check66 days agoChange DetectedDifference0.4%

Stay in the know with updates to AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page.